Congressional committee cuts funding to IARC over WHO agency’s controversial glyphosate-cancer finding

csd blog iarc office
Image: Wikimedia Commons

The House Committee on Appropriations has withheld funding for the WHO International Agency for Research on Cancer—which receives about $2 million from the United States per year—because of controversy over the agency’s label for glyphosate, a chemical commonly used in weedkillers.

In a March 2015 review …. IARC labeled the weedkiller as “probably carcinogenic in humans,” based on limited evidence in humans for non-Hodgkin lymphoma, and “sufficient evidence” in animals.


IARC’s conclusions on glyphosate, made by a working group of 17 scientists from 11 countries, ran counter to guidelines of the U.S. Environmental Protection Agency and the European Food Safety Authority. EPA said glyphosate has “low toxicity to humans,” and an EFSA study in November 2015 found glyphosate “unlikely to be carcinogenic.”


Read full, original article: House committee defoliates NIH funding for WHO program that declares weedkiller Roundup a carcinogen (Behind Paywall)

Related article:  EU renews glyphosate herbicide license for 5 years, ending 'heated debate'
Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Here’s where GM crops are grown around the world today

Infographic: Here’s where GM crops are grown around the world today

Do you know where biotech crops are grown in the world? This updated ISAAA infographics show where biotech crops were ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
Send this to a friend